Stock Markets March 2, 2026

Shares in Major European Shippers Jump as Middle East Tensions Force Reroutes

Maersk and Hapag-Lloyd lead gains after carriers avoid Strait of Hormuz; tanker and RoRo names also advance

By Sofia Navarro FRO
Shares in Major European Shippers Jump as Middle East Tensions Force Reroutes
FRO

European shipping stocks advanced after carriers rerouted vessels around key Middle East chokepoints, tightening available capacity and increasing expectations of higher freight costs. Maersk and Hapag-Lloyd recorded notable gains as companies suspended transits through the Strait of Hormuz and elected to sail around Africa.

Key Points

  • Maersk shares rose 7%, hitting their highest level since March 2, 2023, and Hapag-Lloyd shares increased 4%.
  • Maersk, Hapag-Lloyd and CMA CGM began rerouting ships around Africa, avoiding the Suez Canal and Bab el-Mandeb after U.S. and Israeli strikes on Iran and the closure of the Strait of Hormuz.
  • Nordic tanker and RoRo names gained: Torm and Frontline rose about 5%, while Hoegh Autoliners climbed 3.6% - sectors affected include container shipping, tanker operators, and RoRo shipping.

Shares of several European shipping firms climbed on Monday as a surge in Middle East hostilities prompted major carriers to alter routing plans, reducing near-term global shipping capacity and heightening expectations for rising freight rates.

Maersk saw its shares jump 7%, reaching their strongest level since March 2, 2023. Hapag-Lloyd shares climbed 4% during the same trading session.

On Sunday, three leading container lines - Maersk, Hapag-Lloyd and CMA CGM - initiated rerouting of vessels to sail around Africa rather than transit the Suez Canal and the Bab el-Mandeb. This move followed U.S. and Israeli strikes on Iran and the closure of the Strait of Hormuz. Both Maersk and Hapag-Lloyd subsequently announced they would suspend all vessel crossings of the Strait of Hormuz until further notice.

Brokerage analysts and market commentators said that continued disruption in the region is likely to push freight rates higher, with the effect compounded by rising oil prices. The reduction in direct east-west sailings through the Middle East corridor effectively tightens available capacity as ships take longer, alternative routes.

The ripple effect extended to European and Nordic tanker stocks, where Copenhagen-listed Torm and Oslo-listed Frontline each rose by about 5%. Norway's roll-on/roll-off shipper Hoegh Autoliners advanced approximately 3.6%.

The market reaction reflected investor recalibration of near-term supply conditions in container shipping and related maritime sectors. With prominent carriers pausing transits through a major oil and shipping artery and electing longer voyages around the Cape of Good Hope, trading desks and freight forwarders are likely to reassess capacity and pricing assumptions in coming days.

At present, the situation remains fluid. Companies that have suspended Gulf transits have not issued timelines for resuming those routes, leaving the duration of the capacity impact and its ultimate effect on freight rates and fuel costs uncertain.

Risks

  • Suspension of vessel crossings in the Strait of Hormuz by Maersk and Hapag-Lloyd creates uncertainty over the duration of disrupted routes - this affects container shipping capacity and scheduling.
  • Continued regional disruption could push freight rates higher and increase shipping costs, with concurrent upward pressure on fuel costs due to rising oil prices - impacting logistics and trade-exposed sectors.
  • Rerouting ships around Africa lengthens voyages and could tighten available tonnage, heightening the risk of congestion and delays across ports and supply chains.

More from Stock Markets

Analyst Says Google-Linked Dip in Memory Stocks Is a Buying Opportunity Mar 25, 2026 Istanbul bourse edges up as trade, machinery and real estate stocks lead gains Mar 25, 2026 Jefferies Picks Three SMID Biotech Names It Believes Are Poised to Deliver Growth Mar 25, 2026 Brazil Unveils First Locally Assembled Gripen Fighter, Marking a Domestic Milestone Mar 25, 2026 Corcept Therapeutics Soars After FDA Clears Relacorilant for Specific Platinum-Resistant Ovarian Cancers Mar 25, 2026